Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections (WE SENSE)
Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections: The WE SENSE Study
Sponsor: Canadian Institutes of Health Research (CIHR)
A NA clinical study on Influenza and Viral Respiratory Tract Infection, this trial is completed. The trial is conducted by Canadian Institutes of Health Research (CIHR) and has accumulated 8 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Jun 2025 — Sep 2025 [monthly]
Completed NA
-
Apr 2025 — Jun 2025 [monthly]
Completed NA
-
Sep 2024 — Apr 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2022 — Dec 2023 [monthly]
Active Not Recruiting NA
Status: Completed → Active Not Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Completed NA
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Institutes of Health Research (CIHR)
- Emily McDonald
- Université de Montréal
For direct contact, visit the study record on ClinicalTrials.gov .